Love to believe that but they have been negotiating that for 3 years, yet they brought at the last 3 capital raises 0.31, 0.28, 0.15c There is nothing in my mind that is significant enough to prevent directors and management from buying, if in doubt ring them
News flow Multi site sale..... The market is aware of this they have been talking about since last year, wont stop directors from buying its in the public domain One or two one off sales..... not significant. wont stop directors from buying its in the public domain ECCMID post presentation.......interesting and looking forward to seeing it but not significant. wont stop directors from buying its in the public domain FDA approval....not due till say May and market knows about it. Distributor.... wont happen till the others happen
Potential distributors want to have a product de-risked that means Sales and FDA approval.
The exciting thing is that it costs about 40 Million to bring a Medical device to market. yet LBT is valued by the market at 12 Million, I know that if i am embarrassed to own them I'm sure they are a little embarrassed by the share price.
"It is expensive to bring a medical device to market. A 2010 Stanford study1identified the average cost to bring a 510(k) product from concept to market at $31 million. Greater than 77 percent of the cost—approximately $24 million—was consumed on regulatory and FDA-related activities. The cost of a PMA averaged $94 million, with $75 million spent on FDA-linked stages—nearly 80 percent of the total amount of bringing medtech devices to market launch"